Dual in domestic immunosuppressant market

The duel between Astellas and Hanmi Pharm has reached another round on the local market.

Hanmi Pharm rolled out its tacrolimus generic on November 25, with its own solid-dispersion technology to enhance solubility of tacrolimus.

Tacrolimus is an immunosuppressant drug whose main use is after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk o...